← Insider buys
REPH

Recro Pharma, Inc.

Possible Member of 10% Group, 10% James E Flynn sold $706K of Recro Pharma, Inc.

Sold$706,226
$6.39Price
110,447Shares
−5%Stake

What REPH did after the filing

Prices for REPH after this filing aren't in yet.

Traded Mon, Jun 12. Filed Wed, Jun 14, 8:13 PM ET, after the close. Not investment advice.